Search - tctmd.com

Displaying 841 - 860 of 2250

Sort: Relevancy | Date

News Daily News

Majority of Deaths Over Time in STEMI Patients Not Cardiovascular Related

November 17, 2014

News Daily News

La Mayoría de Muertes que sobrevienen en Pacientes STEMI No se Deben a Causas Cardiovasculares

November 17, 2014

News Daily News

La Edad Influye en Pacientes con ACV Agudos Tratados con un Recuperador de Stent

November 17, 2014

News Daily News

EVAR Feasible for Mycotic Aortic Aneurysm, but Risk of Infection High

Yael L. Maxwell

November 17, 2014

News Daily News

EVAR es Viable en el Manejo de Aneurismas Aórticos Micóticos aunque el Riesgo de Infección es Alto

Yael L. Maxwell

November 17, 2014

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Todd Neale

November 17, 2014

News Daily News

Compliance With Follow-up Imaging Poor After EVAR

L.A. McKeown

November 17, 2014

News Daily News

Age Matters in Acute Stroke Patients Treated With Stent Retriever

November 17, 2014

Presentation AHA 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presenter: Dean J. Kereiakes

November 16, 2014

News Conference News AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Conference News AHA 2014

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

Long-Term Better than Short-Term Prasugrel After PES Stenting

November 15, 2014

News Conference News AHA 2014

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Yael L. Maxwell

November 15, 2014

News Conference News AHA 2014

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

November 15, 2014

News Industry News

Boehringer Ingelheim Initiates U.S. Sites in First-Ever Global Phase III Trial of Investigational Antidote in Patients Taking PRADAXA®

November 09, 2014

News Daily News

Un Estudio Pone de Manifiesto el Riesgo Clínico de la EAC No Obstructiva

November 06, 2014

News Daily News

Un Estudio del Mundo Real Revela los Beneficios de Tratar Solo el Vaso Causante en Casos de STEMI

Yael L. Maxwell

November 06, 2014

News Daily News

Study Highlights Clinical Risk of Nonobstructive CAD

November 06, 2014

Advertisement

Majority of Deaths Over Time in STEMI Patients Not Cardiovascular Related

La Mayoría de Muertes que sobrevienen en Pacientes STEMI No se Deben a Causas Cardiovasculares

La Edad Influye en Pacientes con ACV Agudos Tratados con un Recuperador de Stent

EVAR Feasible for Mycotic Aortic Aneurysm, but Risk of Infection High

EVAR es Viable en el Manejo de Aneurismas Aórticos Micóticos aunque el Riesgo de Infección es Alto

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Compliance With Follow-up Imaging Poor After EVAR

Age Matters in Acute Stroke Patients Treated With Stent Retriever

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Long-Term Better than Short-Term Prasugrel After PES Stenting

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

Boehringer Ingelheim Initiates U.S. Sites in First-Ever Global Phase III Trial of Investigational Antidote in Patients Taking PRADAXA®

Un Estudio Pone de Manifiesto el Riesgo Clínico de la EAC No Obstructiva

Un Estudio del Mundo Real Revela los Beneficios de Tratar Solo el Vaso Causante en Casos de STEMI

Study Highlights Clinical Risk of Nonobstructive CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content